Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2006 1
2009 1
2010 1
2011 1
2013 1
2015 2
2016 2
2017 4
2018 2
2020 3
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
CK2-An Emerging Target for Neurological and Psychiatric Disorders.
Castello J, Ragnauth A, Friedman E, Rebholz H. Castello J, et al. Among authors: rebholz h. Pharmaceuticals (Basel). 2017 Jan 5;10(1):7. doi: 10.3390/ph10010007. Pharmaceuticals (Basel). 2017. PMID: 28067771 Free PMC article. Review.
CK2 negatively regulates Galphas signaling.
Rebholz H, Nishi A, Liebscher S, Nairn AC, Flajolet M, Greengard P. Rebholz H, et al. Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):14096-101. doi: 10.1073/pnas.0906857106. Epub 2009 Aug 3. Proc Natl Acad Sci U S A. 2009. PMID: 19666609 Free PMC article.
22 results